Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
The chickenpox (varicella) vaccine was licensed in the United States in March 1995, with a one-dose childhood schedule recommended that year and a routine second dose added in 2006. That timeline means your age matters: people born before 1980 are generally presumed immune because wild chickenpox circulated widely, while those born between roughly 1980 and 1995 may have missed both natural infection and vaccination and could still be susceptible. Anyone vaccinated between 1995 and 2006 may have received only one dose and may benefit from a catch-up second dose, and adults with uncertain history can be tested or simply vaccinated. Shingles risk later in life, pregnancy, and weakened immunity add further considerations. There are several important details that depend on your birth year and health history, so see below to understand more.
If you are dealing with an itchy rash, fever, or blisters right now and are unsure whether it is chickenpox, shingles, or something else entirely, guessing can delay care that works best in the first 24 to 72 hours. A free, instant, online symptom check walks you through your specific symptoms, flags what conditions fit the pattern, and points you toward the right next step, whether that is a pharmacy, a same-day appointment, or urgent care. It takes a couple of minutes, requires no insurance or sign-up, and gives you clearer language to bring to a clinician so nothing important gets missed.
Last reviewed for medical accuracy: 10/01/2026
When did the chickenpox vaccine come out, and what that means for your age group
Chickenpox (varicella) used to be a near-universal childhood illness. In the mid-1990s, a safe and effective vaccine changed that. Knowing exactly when the chickenpox vaccine came out—and how it has been rolled out—can help you understand your own immunity, your risk of complications, and whether you or your children need catch-up shots.
Timeline: when did the chickenpox vaccine come out?
• 1995 – Merck’s live-attenuated varicella vaccine (Varivax) was licensed by the U.S. Food and Drug Administration (FDA).
• 1996 – The Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination of healthy children aged 12–18 months, plus catch-up for older children and adolescents.
• 2000 – ACIP expanded catch-up recommendations to include all susceptible children aged 19–35 months.
• 2006 – A second dose became recommended for children, adolescents and adults without evidence of immunity, improving long-term protection.
• 2012 – ACIP defined evidence of varicella immunity (history of vaccination, laboratory confirmation, or birth before 1980 for most U.S. adults).
• 2019–2021 – Some states refined school-entry requirements to include two doses for stronger community protection.
What this means for your age group
Depending on your birth year, you may have natural immunity from infection or vaccine-derived immunity. Here’s how to interpret your own risk and next steps.
Born before 1995
• Likely had chickenpox as a child – natural infection typically gives lifelong immunity.
• Natural immunity is strong, but shingles (reactivation of varicella) risk rises with age.
• If you never had chickenpox, you may still be susceptible and should consider vaccination.
Born 1995–1996 (transition cohort)
• First year the vaccine was licensed and recommended. Some in this group were vaccinated; others weren’t.
• Check your immunization record or ask your doctor for varicella antibody testing.
• If you lack clear evidence of immunity (no documented vaccine or lab confirmation), a two-dose catch-up is advised.
Born 1997–2005
• Routine one-dose schedule in place, but two-dose catch-up started in 2006.
• One dose protects about 80–85% from any disease and 98% from severe disease. A second dose raises protection above 95%.
• If you only received one dose, talk to your doctor about completing the two-dose series for better long-term coverage.
Born 2006 and later
• Two-dose schedule at 12–15 months and 4–6 years old is standard.
• Over 95% effectiveness in preventing infection; virtually all severe cases are avoided.
• School-entry requirements generally enforce two doses, reducing community spread.
Why it matters today
• Reduced chickenpox cases
Since routine vaccination began, U.S. cases have dropped over 90%. Fewer children miss school and fewer families face complications like bacterial skin infections or pneumonia.
• Herd immunity
High vaccination rates keep outbreaks rare and protect those who can’t be vaccinated (infants, pregnant women, immunocompromised individuals).
• Shingles considerations
Natural infection increases shingles risk roughly three- to five-fold. Childhood vaccination appears to lower shingles rates in vaccinated adults. A separate shingles vaccine is recommended at age 50+.
• Catch-up and adult vaccination
If you fall into a gap year or never completed two doses, it’s not too late. Catch-up immunization is safe and effective for adolescents and adults without evidence of immunity.
Next steps for peace of mind
• Check your records
Look for varicella vaccine dates or lab confirmation. If you can’t find proof, speak with your doctor about antibody testing.
• Consider vaccination or catch-up
A simple two-dose series can close immunity gaps. Side effects are generally mild (soreness, low-grade fever).
• Monitor symptoms
If you develop rash, fever or other concerning signs, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/).
• Watch for serious signs
Seek immediate medical care for high fever, widespread rash, difficulty breathing, severe headaches or confusion.
• Speak to a doctor
Always discuss any life-threatening or serious health concerns with a qualified health professional. Varicella complications can be serious in adults, pregnant women and those with weakened immunity.
Key takeaways
Knowing “when did the chickenpox vaccine come out” helps you place your own immunity into context. Whether you were born before the vaccine existed or after two-dose schedules were routine, understanding your risk and options ensures you and your family stay protected against chickenpox and its potential complications. Always keep your immunizations up to date and consult your healthcare provider for personalized advice.
(References)
* Boda D, Bartyik K, Szüts P, Turi S. Active immunization of children exposed to varicella infection in a hospital ward using live attenuated varicella vaccine given subcutaneously or intracutaneously. Acta Paediatr Hung. 1986;27(3):247-52. PMID: 3022772.
* Brunell PA, Argaw T. Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics. 2000 Aug;106(2):E28. doi: 10.1542/peds.106.2.e28. PMID: 10920184.
* Sabella C. Which children and adults should receive the chickenpox vaccine? Cleve Clin J Med. 2002 Dec;69(12):1000-1. doi: 10.3949/ccjm.69.12.1000. PMID: 12546274.
* Bruel H, Chabrolle JP, El Khoury E, Poinsot J, Amusini P, Beurrier J. [Two cases of congenital varicella syndrome: plea for the varicella vaccine]. Arch Pediatr. 2004 Mar;11(3):216-8. doi: 10.1016/j.arcped.2003.12.016. PMID: 14992768.
* Walter EB, Snyder MA, Clements DA, Katz SL. Large injection site reactions after a second dose of varicella vaccine. Pediatr Infect Dis J. 2008 Aug;27(8):757-9. doi: 10.1097/INF.0b013e31816fc323. PMID: 18574438.
* Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008. J Infect Dis. 2011 Feb 15;203(4):509-12. doi: 10.1093/infdis/jiq081. Epub 2011 Jan 3. PMID: 21199882; PMCID: PMC3071238.
* Kawamura Y, Suzuki D, Kono T, Miura H, Kozawa K, Mizuno H, Yoshikawa T. A Case of Aseptic Meningitis Without Skin Rash Caused by Oka Varicella Vaccine. Pediatr Infect Dis J. 2022 Jan 1;41(1):78-79. doi: 10.1097/INF.0000000000003316. PMID: 34591803.
* Sugai T, Fujita Y, Yamada S, Fukushi S, Inamura E, Hatakeyama K, Shimizu S. Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash. J Pediatr. 2022 Dec;251:218-219. doi: 10.1016/j.jpeds.2022.08.032. Epub 2022 Aug 23. PMID: 36027973.
* Rodríguez-García J, Onieva-García MA, García Cenoz M, García Erce JA. [An inactive vaccine for primary immunization to chickenpox]. Rev Esp Quimioter. 2022 Dec;35(6):587-588. doi: 10.37201/req/071.2022. Epub 2022 Oct 25. PMID: 36282185; PMCID: PMC9728606.
* Naureckas Li C, Edwards KM, Kaplan SL, Marshall GS, Parker S, Healy CM. What's Old Is New Again: Varicella. Pediatrics. 2026 Sep 1;158(3). doi: 10.1542/peds.2026-076519. PMID: 42595342.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.